Melodia Therapeutics and Alivexis sign exclusive licence agreement for Cathepsin C Inhibitor program… BusinessWire Jun 21, 2024 Alivexis and Melodia will leverage their respective expertise in drug discovery research and development with the aim of obtaining…
